Trial Profile
Effects of immune-globulin (Gamunex) in patients with sickle cell disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2015
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Sickle cell anaemia
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 03 Mar 2015 New trial record